Showing results (51-60 of 89) with videos related to
Sort By:
Pageof 9
In Vivo (Athens, Greece)|April 29, 2021
Therapeutic and Clinical Outcomes of Robot-assisted Partial Nephrectomy Versus Cryoablation for T1 Renal Cell CarcinomaToshihiro Uemura, Taigo Kato, Akira Nagahara, et al.Oncotarget|February 5, 2017
MiR-21-5p in urinary extracellular vesicles is a novel biomarker of urothelial carcinomaKyosuke Matsuzaki, Kazutoshi Fujita, Kentaro Jingushi, et al.Anticancer Research|December 7, 2016
Clinical Significance of the Apparent Diffusion Coefficient Ratio in Prostate Cancer Treatment with Intensity-modulated RadiotherapyHiroko Yamaguchi, Masatoshi Hori, Osamu Suzuki, et al.Oncotarget|August 6, 2016
Decreased fucosylated PSA as a urinary marker for high Gleason score prostate cancerKazutoshi Fujita, Takuji Hayashi, Kyosuke Matsuzaki, et al.Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|July 24, 2018
[A CASE OF SUCCESSFUL RECOVERY OF RENAL ALLOGRAFT FUNCTION FOLLOWING A DIAGNOSIS OF THROMBOTIC MICROANGIOPATHY CLINICALLY MADE IN THE IMMEDIATE POST-TRANSPLANT PERIOD]Yujiro Hayashi, Akira Nagahara, Atsunari Kawashima, et al.Frontiers in Oncology|May 31, 2021
Genomic and Pathological Characterization of Multiple Renal Cell Carcinoma Regions in Patient With Tuberous Sclerosis Complex: A Case ReportTetsuya Yamamoto, Taigo Kato, Koji Hatano, et al.Clinical Case Reports|October 19, 2019
A case of primary aldosteronism with resistant hypertension successfully treated by unilateral adrenalectomy after unsuccessful classification of subtype in adrenal venous samplingRyo Nakamaru, Koichi Yamamoto, Satoko Nozato, et al.Molecular Oncology|June 14, 2020
TERT C228T mutation in non-malignant bladder urothelium is associated with intravesical recurrence for patients with non-muscle invasive bladder cancerYujiro Hayashi, Kazutoshi Fujita, Satoshi Nojima, et al.Plos One|August 10, 2018
STAT3 expression is a prognostic marker in upper urinary tract urothelial carcinomaKyosuke Matsuzaki, Kazutoshi Fujita, Yujiro Hayashi, et al.Oncotarget|May 15, 2018
Increased level and fragmentation of plasma circulating cell-free DNA are diagnostic and prognostic markers for renal cell carcinomaYoshiyuki Yamamoto, Motohide Uemura, Kosuke Nakano, et al.Pageof 9